U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Delayed ability to crawl

MedGen UID:
1772845
Concept ID:
C5421628
Finding
HPO: HP:0033128

Definition

A failure to achieve the ability to crawl at an appropriate developmental stage. Normal infant motor development is marked by a series of postural milestones including learning to crawl on hands and knees between the ages of 6 and 10 months. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVDelayed ability to crawl

Conditions with this feature

Severe intellectual disability-progressive spastic diplegia syndrome
MedGen UID:
767363
Concept ID:
C3554449
Disease or Syndrome
CTNNB1 neurodevelopmental disorder (CTNNB1-NDD) is characterized in all individuals by mild-to-profound cognitive impairment and in up to 39% of reported individuals by exudative vitreoretinopathy, an ophthalmologic finding consistent with familial exudative vitreoretinopathy (FEVR). Other common findings include truncal hypotonia, peripheral spasticity, dystonia, behavior problems, microcephaly, and refractive errors and strabismus. Less common features include intrauterine growth restriction, feeding difficulties, and scoliosis.
Intellectual disability, autosomal recessive 42
MedGen UID:
862780
Concept ID:
C4014343
Disease or Syndrome
Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities (NEDDSBA) is an autosomal recessive neurodevelopmental disorder characterized by severely delayed global development, with hypotonia, impaired intellectual development, and poor or absent speech. Most patients have spasticity with limb hypertonia and brisk tendon reflexes. Additional features include nonspecific dysmorphic facial features, structural brain abnormalities, and cortical visual impairment (summary by Bosch et al., 2015). Novarino et al. (2014) labeled the disorder 'spastic paraplegia-67' (SPG67). The disorder is caused by a defect in glycosylphosphatidylinositol (GPI) biosynthesis. For a discussion of genetic heterogeneity of GPI biosynthesis defects, see GPIBD1 (610293).
ZTTK syndrome
MedGen UID:
934663
Concept ID:
C4310696
Disease or Syndrome
ZTTK syndrome (ZTTKS) is a severe multisystem developmental disorder characterized by delayed psychomotor development and intellectual disability. Affected individuals have characteristic dysmorphic facial features, hypotonia, poor feeding, poor overall growth, and eye or visual abnormalities. Most patients also have musculoskeletal abnormalities, and some have congenital defects of the heart and urogenital system. Brain imaging usually shows developmental abnormalities such as gyral changes, cortical and/or cerebellar atrophy, and thin corpus callosum (summary by Kim et al., 2016).
Intellectual disability, autosomal dominant 43
MedGen UID:
934738
Concept ID:
C4310771
Mental or Behavioral Dysfunction
HIVEP2-related intellectual disability is a neurological disorder characterized by moderate to severe developmental delay and intellectual disability and mild physical abnormalities (dysmorphic features). Early symptoms of the condition include weak muscle tone (hypotonia) and delayed development of motor skills, such as sitting, standing, and walking. After learning to walk, many affected individuals continue to have difficulty with this activity; their walking style (gait) is often unbalanced and wide-based. Speech is also delayed, and some people with this condition never learn to talk. Most people with HIVEP2-related intellectual disability also have unusual physical features, such as widely spaced eyes (hypertelorism), a broad nasal bridge, or fingers with tapered ends, although there is no characteristic pattern of such features among affected individuals. Many people with the condition exhibit neurodevelopmental disorders, such as hyperactivity, attention deficit disorder, aggression, anxiety, and autism spectrum disorder, which is a group of developmental disorders characterized by impaired communication and social interaction.\n\nOther features of HIVEP2-related intellectual disability include mild abnormalities in the structure of the brain and an abnormally small brain and head size (microcephaly). Less common health problems include seizures; recurrent ear infections; and eye disorders, such as eyes that do not look in the same direction (strabismus), "lazy eye" (amblyopia), and farsightedness (hyperopia). Some people with HIVEP2-related intellectual disability have gastrointestinal problems, which can include backflow of acidic stomach contents into the esophagus (gastroesophageal reflux) and constipation.
Developmental and epileptic encephalopathy, 51
MedGen UID:
1372686
Concept ID:
C4479208
Disease or Syndrome
Developmental and epileptic encephalopathy-51 (DEE51) is an autosomal recessive severe neurodevelopmental disorder characterized by onset of intractable seizures and hypotonia in the first days or weeks of life. Affected individuals have severely delayed psychomotor development and may show abnormal movements. Brain imaging shows nonspecific abnormalities, such as cerebral atrophy, cerebellar atrophy, and delayed myelination. Laboratory studies showed increased lactate, suggesting mitochondrial dysfunction (summary by Ait-El-Mkadem et al., 2017). For a discussion of genetic heterogeneity of DEE, see 308350.
Combined oxidative phosphorylation deficiency 50
MedGen UID:
1753519
Concept ID:
C5436623
Disease or Syndrome
Developmental and epileptic encephalopathy 97
MedGen UID:
1794209
Concept ID:
C5561999
Disease or Syndrome
Developmental and epileptic encephalopathy-97 (DEE97) is characterized by developmental delay, epileptic encephalopathy, and impaired intellectual development. Other clinical features may include autistic features and hypotonia. For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
Brunet-Wagner neurodevelopmental syndrome
MedGen UID:
1794266
Concept ID:
C5562056
Disease or Syndrome
Brunet-Wagner neurodevelopmental syndrome (BRUWAG) is an autosomal recessive disorder characterized by infantile hypotonia and severely impaired development affecting both motor and cognitive skills. Affected individuals either do not achieve independent ambulation or walk with an unsteady gait; those who walk may lose the ability due to spasticity of the lower limbs. They have absent language, poor or absent social skills, and behavioral abnormalities. Most have variable ocular findings, including nystagmus, strabismus, optic atrophy, myopia, or hypermetropia (summary by Brunet et al., 2020 and Samra et al., 2021).

Recent clinical studies

Etiology

Winders P, Wolter-Warmerdam K, Hickey F
J Intellect Disabil Res 2019 Apr;63(4):346-356. Epub 2018 Dec 21 doi: 10.1111/jir.12580. PMID: 30575169
Mchome Z, Bailey A, Darak S, Haisma H
Matern Child Nutr 2019 Jul;15(3):e12769. Epub 2019 Feb 6 doi: 10.1111/mcn.12769. PMID: 30556365Free PMC Article
Stansfield S, Dennis C, Altman R, Smith J, Larin H
Assist Technol 2018;30(2):84-90. Epub 2017 Feb 2 doi: 10.1080/10400435.2016.1262479. PMID: 28152334
Christensen LH, Høyer BB, Pedersen HS, Zinchuk A, Jönsson BAG, Lindh C, Dürr DW, Bonde JP, Toft G
Neurotoxicology 2016 Mar;53:236-245. Epub 2016 Feb 17 doi: 10.1016/j.neuro.2016.02.007. PMID: 26899398
Srinivasan SM, Bhat AN
Infant Behav Dev 2016 Feb;42:128-41. Epub 2016 Jan 22 doi: 10.1016/j.infbeh.2015.12.003. PMID: 26803417Free PMC Article

Diagnosis

Msall ME, Limperopoulos C, Park JJ
Minerva Pediatr 2009 Aug;61(4):415-24. PMID: 19752850
Suzuki H, Matsuzaka T, Hirayama Y, Sakuragawa N, Arima M, Tateno A, Tojo M, Suzuki Y
J Child Neurol 1986 Apr;1(2):137-41. doi: 10.1177/088307388600100208. PMID: 3598118

Therapy

Christensen LH, Høyer BB, Pedersen HS, Zinchuk A, Jönsson BAG, Lindh C, Dürr DW, Bonde JP, Toft G
Neurotoxicology 2016 Mar;53:236-245. Epub 2016 Feb 17 doi: 10.1016/j.neuro.2016.02.007. PMID: 26899398
Sun H, Como PG, Downey LC, Murphy D, Ariagno RL, Rodriguez W
J Perinatol 2015 Oct;35(10):867-74. Epub 2015 Aug 6 doi: 10.1038/jp.2015.87. PMID: 26248129

Prognosis

Wagner A, Pals C, de Blecourt CM, Sarampalis A, Başkent D
Adv Exp Med Biol 2016;894:297-306. doi: 10.1007/978-3-319-25474-6_31. PMID: 27080670
Sun H, Como PG, Downey LC, Murphy D, Ariagno RL, Rodriguez W
J Perinatol 2015 Oct;35(10):867-74. Epub 2015 Aug 6 doi: 10.1038/jp.2015.87. PMID: 26248129
Yokochi K
Brain Dev 2001 Aug;23(5):327-32. doi: 10.1016/s0387-7604(01)00232-7. PMID: 11504605

Clinical prediction guides

Winders P, Wolter-Warmerdam K, Hickey F
J Intellect Disabil Res 2019 Apr;63(4):346-356. Epub 2018 Dec 21 doi: 10.1111/jir.12580. PMID: 30575169
Christensen LH, Høyer BB, Pedersen HS, Zinchuk A, Jönsson BAG, Lindh C, Dürr DW, Bonde JP, Toft G
Neurotoxicology 2016 Mar;53:236-245. Epub 2016 Feb 17 doi: 10.1016/j.neuro.2016.02.007. PMID: 26899398
Srinivasan SM, Bhat AN
Infant Behav Dev 2016 Feb;42:128-41. Epub 2016 Jan 22 doi: 10.1016/j.infbeh.2015.12.003. PMID: 26803417Free PMC Article
Sun H, Como PG, Downey LC, Murphy D, Ariagno RL, Rodriguez W
J Perinatol 2015 Oct;35(10):867-74. Epub 2015 Aug 6 doi: 10.1038/jp.2015.87. PMID: 26248129
Msall ME, Limperopoulos C, Park JJ
Minerva Pediatr 2009 Aug;61(4):415-24. PMID: 19752850

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...